“Pharmacological Blockade of Protease-Activated Receptor 2 Improves Airway Remodeling and Lung Inflammation in Experimental Allergic Asthma”. 2023. Brazilian Journal of Pharmaceutical Sciences 58 (February). https://doi.org/10.1590/s2175-97902022e201089.